These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Biotechnology inventions in the health care environment: what to patent and how to avoid defeat. Murashige KR Benders Health Care Law Mon; 1995 Dec; ():3-10. PubMed ID: 10158648 [No Abstract] [Full Text] [Related]
3. Australia experiments with 'experimental use' exemption. McBratney A; Nielsen K; McMillan F Nat Biotechnol; 2004 Aug; 22(8):1023-5. PubMed ID: 15286651 [TBL] [Abstract][Full Text] [Related]
10. European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversy. Paradise J Food Drug Law J; 2004; 59(1):133-54. PubMed ID: 15190928 [No Abstract] [Full Text] [Related]
12. Opinions evolve on Kauffman patent. Dove A Nat Biotechnol; 2000 Apr; 18(4):373. PubMed ID: 10748506 [No Abstract] [Full Text] [Related]
13. Research tool patents: tips for facing a "pay up now or litigate" ultimatum. Gogoris A; Ancona P Nat Biotechnol; 2001 Nov; 19(11):1075-7. PubMed ID: 11689855 [No Abstract] [Full Text] [Related]
14. Bungled law threatens Italian tech transfer. Meldolesi A Nat Biotechnol; 2001 Nov; 19(11):996-7. PubMed ID: 11689829 [No Abstract] [Full Text] [Related]
15. US to rule on research patent. Ruttimann J Nature; 2006 Mar; 440(7084):587. PubMed ID: 16572133 [No Abstract] [Full Text] [Related]
16. Nontraditional publications and their effect on patentable inventions. Garabedian TE Nat Biotechnol; 2002 Apr; 20(4):401-2. PubMed ID: 11923849 [No Abstract] [Full Text] [Related]
17. To patent or not to patent: the European Union's new biotech directive. Nenow L Houst J Int Law; 2001; 23(3):569-607. PubMed ID: 12769115 [No Abstract] [Full Text] [Related]